Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 4
2022 5
2023 8
2024 8
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean eloumou g (1 results)?
Gestion optimisée des intrants pour une réponse efficace en contexte de pandémie au Cameroun.
Fokam J, Abega Abega CA, Jagni Semengue EN, Abba A, Takou D, Beloumou GA, Djupsa Ndjeyep SC, Nka AD, Anguechia Gouissi DH, Ngwese Tambe DA, Collins C, Christelle Ka'e A, Tommo Tchouaket MC, Nayang Mundo RA, Kengni Ngueko AM, Etame NK, F Moko LG, Molimbou E, Togna Pabo WL, Patricia Tueguem P, Fainguem N, Mba LF, Yatchou LG, Ibnou N, Bienvenu Onana T, Boum Y 2nd, Etoundi Mballa AG, Ndjolo A. Fokam J, et al. Among authors: beloumou ga. J Public Health Afr. 2025 May 30;16(1):858. doi: 10.4102/jphia.v16i1.858. eCollection 2025. J Public Health Afr. 2025. PMID: 40469400 Free PMC article. French.
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens.
Fokam J, Chenwi CA, Tala V, Takou D, Santoro MM, Teto G, Dambaya B, Anubodem F, Semengue ENJ, Beloumou G, Djupsa S, Assomo E, Fokunang C, Alteri C, Billong S, Bouba NP, Ajeh R, Colizzi V, Mbanya D, Ceccherini-Silberstein F, Perno CF, Ndjolo A. Fokam J, et al. Among authors: beloumou g. Viruses. 2023 Jun 28;15(7):1458. doi: 10.3390/v15071458. Viruses. 2023. PMID: 37515146 Free PMC article.
HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.
Togna Pabo WLR, Fokam J, Njume D, Takou D, Santoro MM, Nyasa RB, Chenwi C, Mpouel ML, Beloumou G, Jagni ESN, Nka AD, Ka'e AC, Teto G, Dambaya B, Djupsa S, Gouissi Anguechia DH, Evariste M, Kamta C, Bala L, Lambo V, Halle-Ekane EG, Colizzi V, Perno CF, Ndjolo A, Ndip Ndip R. Togna Pabo WLR, et al. Among authors: beloumou g. PLoS One. 2023 Oct 25;18(10):e0293326. doi: 10.1371/journal.pone.0293326. eCollection 2023. PLoS One. 2023. PMID: 37878637 Free PMC article.
Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status.
Aissatou A, Fokam J, Semengue ENJ, Takou D, Ka'e AC, Ambe CC, Nka AD, Djupsa SC, Beloumou G, Ciaffi L, Tchouaket MCT, Nayang ARM, Pabo WLT, Essomba RG, Halle EGE, Okomo MC, Bissek AZ, Leke R, Boum Y 2nd, Mballa GAE, Montesano C, Perno CF, Colizzi V, Ndjolo A. Aissatou A, et al. Among authors: beloumou g. Front Immunol. 2023 Mar 8;14:1155855. doi: 10.3389/fimmu.2023.1155855. eCollection 2023. Front Immunol. 2023. PMID: 37090738 Free PMC article.
Genomic surveillance of SARS-CoV-2 reveals highest severity and mortality of delta over other variants: evidence from Cameroon.
Fokam J, Essomba RG, Njouom R, Okomo MA, Eyangoh S, Godwe C, Tegomoh B, Otshudiema JO, Nwobegahay J, Ndip L, Akenji B, Takou D, Moctar MMM, Mbah CK, Ndze VN, Maidadi-Foudi M, Kouanfack C, Tonmeu S, Ngono D, Nkengasong J, Ndembi N, Bissek AZK, Mouangue C, Ndongo CB, Epée E, Mandeng N, Kamso Belinga S, Ayouba A, Fernandez N, Tongo M, Colizzi V, Halle-Ekane GE, Perno CF, Ndjolo A, Ndongmo CB, Shang J, Esso L, de-Tulio O, Diagne MM, Boum Y 2nd, Mballa GAE, Njock LR; Genomic Surveillance Study Group. Fokam J, et al. Sci Rep. 2023 Dec 8;13(1):21654. doi: 10.1038/s41598-023-48773-3. Sci Rep. 2023. PMID: 38066020 Free PMC article.
Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies.
Ka'e AC, Nanfack AJ, Ambada G, Santoro MM, Takou D, Semengue ENJ, Nka AD, Bala MLM, Endougou ON, Elong E, Beloumou G, Djupsa S, Gouissi DH, Fainguem N, Tchouaket MCT, Sosso SM, Kesseng D, Ndongo FA, Sonela N, Kamta ACL, Tchidjou HK, Ndomgue T, Ndiang STM, Nlend AEN, Nkenfou CN, Montesano C, Halle-Ekane GE, Cappelli G, Tiemessen CT, Colizzi V, Ceccherini-Silberstein F, Perno CF, Fokam J. Ka'e AC, et al. Among authors: beloumou g. Front Immunol. 2023 Aug 14;14:1239877. doi: 10.3389/fimmu.2023.1239877. eCollection 2023. Front Immunol. 2023. PMID: 37646023 Free PMC article.
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens.
Fokam J, Chenwi CA, Takou D, Santoro MM, Tala V, Teto G, Beloumou G, Semengue ENJ, Dambaya B, Djupsa S, Kembou E, Bouba NP, Ajeh R, Cappelli G, Mbanya D, Colizzi V, Ceccherini-Silberstein F, Perno CF, Ndjolo A. Fokam J, et al. Among authors: beloumou g. Viruses. 2023 Aug 2;15(8):1683. doi: 10.3390/v15081683. Viruses. 2023. PMID: 37632026 Free PMC article.
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model.
Semengue ENJ, Fokam J, Etame NK, Molimbou E, Chenwi CA, Takou D, Mossiang L, Meledie AP, Yagai B, Nka AD, Dambaya B, Teto G, Ka'e AC, Beloumou GA, Djupsa Ndjeyep SC, Abba A, Kengni AMN, Tommo Tchouaket MC, Bouba NP, Billong SC, Sosso SM, Colizzi V, Perno CF, Kouanfack C, Zoung-Kanyi Bissek AC, Eben-Moussi E, Santoro MM, Ceccherini-Silberstein F, Ndjolo A. Semengue ENJ, et al. Among authors: beloumou ga. Viruses. 2022 Dec 21;15(1):18. doi: 10.3390/v15010018. Viruses. 2022. PMID: 36680058 Free PMC article.
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries.
Fokam J, Ngoufack Jagni Semengue E, Armenia D, Takou D, Dambaya B, Teto G, Chenwi CA, Nka AD, Beloumou GA, Ndjeyep SCD, Tchouaket MCT, Fainguem N, Sosso SM, Colizzi V, Perno CF, Ndjolo A, Ceccherini-Silberstein F, Santoro MM. Fokam J, et al. Among authors: beloumou ga. Diagn Microbiol Infect Dis. 2022 Feb;102(2):115574. doi: 10.1016/j.diagmicrobio.2021.115574. Epub 2021 Oct 22. Diagn Microbiol Infect Dis. 2022. PMID: 34864527
Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study.
Fokam J, Mpouel Bala ML, Santoro MM, Takou D, Tala V, Beloumou G, Ngoufack ES, Chenwi C, Pabo Willy Leroi T, Njume D, Teto G, Dambaya B, Djupsa S, Sosso S, Ateba F, Kamta C, Bala L, Njom Nlend AE, Koki Ndombo P, Colizzi V, Perno CF, Ndjolo A. Fokam J, et al. Among authors: beloumou g. HIV Med. 2022 Jul;23(6):629-638. doi: 10.1111/hiv.13220. Epub 2021 Dec 23. HIV Med. 2022. PMID: 34951111 Free article.
29 results